TuisONCY • NASDAQ
add
Oncolytics Biotech Inc
Vorige sluiting
$0,98
Dagwisseling
$0,94 - $1,00
Jaarwisseling
$0,84 - $1,73
Markkapitalisasie
73,55 m USD
Gemiddelde volume
438,63 k
P/V-verhouding
-
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 9,90 m | -10,40% |
Netto inkomste | -9,54 m | 3,85% |
Netto winsgrens | — | — |
Wins per aandeel | -0,12 | 10,29% |
EBITDA | -9,86 m | 10,56% |
Effektiewe belastingkoers | -0,13% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 19,60 m | -50,98% |
Totale bates | 24,26 m | -47,36% |
Totale aanspreeklikheid | 15,20 m | -10,93% |
Totale ekwiteit | 9,06 m | — |
Uitstaande aandele | 77,07 m | — |
Prys om te bespreek | 8,17 | — |
Opbrengs op bates | -87,86% | — |
Opbrengs op kapitaal | -167,51% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -9,54 m | 3,85% |
Kontant van bedrywe | -4,83 m | 19,87% |
Kontant van beleggings | -32,00 k | -100,47% |
Kontant van finansiering | -173,00 k | -100,81% |
Netto kontantverandering | -5,25 m | -123,38% |
Beskikbare kontantvloei | -1,70 m | -171,09% |
Meer oor
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Gestig
1998
Hoofkwartier
Webwerf
Werknemers
29
